Navigation Links
DuPont Tate & Lyle Bio Products Announces Innovation Award Program
Date:1/3/2013

Wilmington, Del. (PRWEB) January 03, 2013

DuPont Tate & Lyle Bio Products Company LLC today announces the launch of an Innovation Award program for companies using its Zemea® Propanediol in their cosmetic and personal care ingredients or formulations. Eligible nominees have either commercialized a finished product for retail or launched another ingredient that contains Zemea® Propanediol from Jan. 1, 2011 through Dec. 31, 2012.

Nominations are being accepted between Jan. 3 and Jan. 31, 2013. Nominations will be judged, compared and evaluated by a panel of experienced leaders in the cosmetics and personal care market. This year’s judges include Steve Herman, chair-elect of the New York Society of Cosmetic Chemists and adjunct professor at Fairleigh Dickinson University, Tom Branna, editor of HAPPI magazine, and Steve Hurff, vice president of marketing and sales, DuPont Tate & Lyle Bio Products. The winning company will be announced on Feb. 25, 2013, the timing to coincide with the Personal Care Products Council annual meeting in Palm Beach, Florida.

Complete details including the nomination form are included here as an attachment or can be downloaded from the company’s website at duponttateandlyle.com/zemea. The winning company will receive an engraved plaque and a contribution of $1,500 will be made on its behalf to an approved charity of its choice.

Zemea® is a natural, 100 percent biobased ingredient made from corn sugar through fermentation and developed for use in the cosmetics and personal care market. It is a high-performance, environmentally sustainable alternative to petroleum-based glycols and glycerin, where the product’s lack of skin irritation, improved moisturization and excellent aesthetic properties are benefits. Zemea® is approved as a natural ingredient by Ecocert and the Natural Products Association; is certified 100 percent biobased by the U.S. Department of Agriculture and has both Kosher and Halal certifications.    

"We are excited to recognize innovative leaders in the cosmetics and personal care market who have chosen Zemea® for its unique and sustainable performance capabilities," said Steve Hurff, vice president of marketing and sales, DuPont Tate & Lyle Bio Products.

DuPont Tate & Lyle Bio Products is a joint venture between DuPont, a global science company, and Tate & Lyle, a world-leading renewable food and industrial ingredients company. DuPont Tate & Lyle Bio Products provides natural and renewably sourced ingredients that do not compromise product performance. For more information on the company’s products, visit http://www.duponttateandlyle.com.

# # #

1/3/13
Zemea® and the circle logo are registered trademarks of DuPont Tate & Lyle Bio Products Company LLC.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10285557.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. DuPont Leader Overviews 2012 Seed Research Pipeline with Investors
2. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
3. DuPont Congratulates David Hula for Highest Overall Yield with Pioneer® hybrid – P2088YHR in 2012 NCGA Corn Yield Contest
4. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
5. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
6. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
7. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
8. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
9. Fifth Cycle of Probiotics & Microbiota Research Grant Announced
10. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
11. Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):